RecruitingNCT02306200
Cardiovascular Health Improvement Project
Sponsor
University of Michigan
Enrollment
15,000 participants
Start Date
Aug 1, 2013
Study Type
OBSERVATIONAL
Conditions
Summary
The goal of this project is to establish a biobank of clinical information, DNA, plasma, and aortic tissue samples from patients with cardiovascular disease as well as healthy controls.
Eligibility
Plain Language Summary
Simplified for easier understanding
This trial is studying the genetic and health factors that lead to problems with the aorta (the main artery in the body) and related blood vessels, including aortic aneurysms, to help improve diagnosis and treatment.
**You may be eligible if...**
- You are 18 or older (or younger with parental consent) and willing to participate
- You have been diagnosed with aortic disease linked to a known or suspected inherited condition
- You have an aortic aneurysm with no known cause
- You have an unusual or rare blood vessel condition in the aorta or its main branches
- You have a family history of aortic or blood vessel disease
- You have another form of cardiovascular disease
- You are a healthy person willing to serve as a comparison subject
**You may NOT be eligible if...**
- You are unwilling or unable to sign the consent form
Talk to your doctor to see if this trial is right for you.
This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.
Interested in this trial?
Get notified about updates and connect with the research team.
Locations(1)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT02306200
Related Trials
Diabetes and Heart Disease Risk in Blacks
NCT000018531 location
Hypertension Explored in Long-term Postpartum Follow-up in Later Life
NCT061870121 location
A Study to Test Whether Vicadrostat (BI 690517) in Combination With Empagliflozin Helps People With Heart Failure and a Weak Pumping Function of the Left Side of the Heart
NCT06935370638 locations
EASi-PROTKT™ - A Study to Test Vicadrostat (BI 690517) Taken Together With Empagliflozin in People With Type 2 Diabetes, High Blood Pressure, and Cardiovascular Disease
NCT070644731152 locations
Impact of Optimized Pacing Strategies on Clinical and Hemodynamic Outcomes in Heart Failure Patients With Pacemaker
NCT075631531 location